In the stage 2 analysis, five markers accurately discriminated between neoplasia and control samples with p < 0.0001 – SFRP2, SFRP4, WIF1, APC1A and APC2 (Table 3); with between 40% and 76% increases in geometric mean values. The gene discussed is SFRP4; the disease is neoplasm.